6EASL Jury.EASL international consensus conference on hepatitis B[J].JHepatol,2003,38(4):533-540.
7Sokal E M,Kellyo A,Mizeerski J,et al.An international doubleblind place co-controlled trial of lamivudine in 286 children with chronic hepatitis B (CHB)[J].J Hepatol,2001,34(Suppl):23.
8Sokal E M.Drug treatment of pediatric chronic hepatitis B[J].Paediatr Drugs,2002,4(6):361-369.
9Liaw Y F,Sung T T,Chow W C,et al.Effects of lamivudine on disease progression and development of liver cancer in advanced chronic hepatitis B:a prospective double-blined placebo-controlled clinical trial[J].Hepatology,2003,38 (Suppl):262.
10Craig A,Sponseller A,Bruce R,et al.Clinical improvement in patients with decompensated liver disease caused by hepatitis B after treatment with lamivudine[J].Liver Transplant,2000,6 (6):715-720.
3[7]Perrillo.How will we use the new antiviral agents for hepatitis B?J Curr Gastroenterol Rep,2002,4(1):63.
4Colonno RJ,Genovesi EV,Medina I,et al.Long-term entecavir treatment result in sustained antiviral efficacy and prolonged life span in the woodchuck model of chronic hepatitis infection J Infect Dis,2001,184:1236-1245.
5Innaimo SF,Seifer M,Bisaeehi GS,et al.Identification of BMS-200475 as potent and selective inhibitor of hepatitis B virus.Antimierob Agents Chemother,1997,41:1444—1448.
6De Man RA,Wolters LMM,Nevens F,et al.Safety and efficacy of oral entecavir given for 28 days in patients with chronic hepatitis B virus infection.Hepatology,2001,34:578—582.
7Levine S,Hernandez D,Yamanaka G,et al.Efficacies of entecavir against lamivudine-resistant hepatitis B virus replication and recombinant polymerases in vitro.Amimicrob Agents Chemother,2002,46:2525-2532.
8Wolters LMM,Hansen BE,Niesters HGM,et al.Viral dynamics during and after entecavir therapy in patients with chronic hepatitis B.J Hepatol,2002,37:137-144.
9Lai CL,Rosmawati M,Lao J,et al.Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection.Gastroenterology,2002,123:1831—1838.
10COLONNO RJ,GENOVESI EV,MEDINA I,et al.Long-term entecavir trertmont result in sustained antiviral efficacy and prolonged life span in the woodchuck model of chronic hepatitis infection[J].J Infect Dis,2001,184:1236-1245.
